Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Tomomi Takei"'
Autor:
Taku Kikuchi, Nobuhiro Tsukada, Moe Nomura, Yuki Kasuya, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
Publikováno v:
Annals of Hematology. 102:1477-1483
Autor:
Shuya Abe, Shinichiro Tago, Kazuaki Yokoyama, Miho Ogawa, Tomomi Takei, Seiya Imoto, Masaru Fuji
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1118
Volume 15
Issue 4
Pages: 1118
Background: To treat diseases caused by genetic variants, it is necessary to identify disease-causing variants in patients. However, since there are a large number of disease-causing variants, the application of AI is required. We propose AI to solve
Autor:
Yuka Wada, Arinobu Tojo, Asako Kobayashi, Satoru Miyano, Eigo Shimizu, Takaaki Konuma, Nozomi Yusa, Mika Ito, Tomomi Takei, Kanya Kondoh, Seiko Kato, Miho Ogawa, Masamichi Isobe, Kazuaki Yokoyama, Rika Kasajima, Satoshi Takahashi, Sousuke Nakamura, Tokiko Nagamura-Inoue, Seiya Imoto, Rui Yamaguchi
Publikováno v:
Blood. 133:2682-2695
This study was performed to assess the utility of tumor-derived fragmentary DNA, or circulating tumor DNA (ctDNA), for identifying high-risk patients for relapse of acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after undergoing myeloa
Autor:
Kanya Kondoh, Miho Ogawa, Nobuhiro Ohno, Nozomi Yusa, Satoru Miyano, Rui Yamaguchi, Kaoru Uchimaru, Tomofusa Fukuyama, Mika Ito, Toyotaka Kawamata, Seiya Imoto, Sousuke Nakamura, Eigo Shimizu, Tomomi Takei, Arinobu Tojo, Reina Takeda, Kazuaki Yokoyama
Publikováno v:
Leukemia & Lymphoma. 60:2821-2824
TCF3 (also known as E2A) on 19p13 encodes a B cell developmental transcription factor [1], and the HLF gene on 17q22 encodes a transcription factor highly expressed in hematopoietic stem cells [2]....
Autor:
Satoru Miyano, Miho Ogawa, Mika Ito, Rika Kasajima, Rui Yamaguchi, Asako Kobayashi, Eigo Shimizu, Kazuaki Yokoyama, Yuka Wada, Sousuke Nakamura, Seiya Imoto, Tomomi Takei, Nozomi Yusa, Tokiko Nagamura-Inoue, Arinobu Tojo
Publikováno v:
International Journal of Hematology. 108:402-410
A growing body of evidence suggests that tumor-derived fragmentary DNA, known as circulating tumor DNA (ctDNA), has the potential to serve as a non-invasive biomarker for disease monitoring. However, in the setting of hematological malignancy, few pu
Autor:
Hiroshi Yotsuyanagi, Mitsuhito Hirano, Toyotaka Kawamata, Kazuaki Yokoyama, Kaoru Uchimaru, Yoichi Imai, Yasunori Ota, Reina Takeda, Arinobu Tojo, Tomomi Takei, Tomohiko Koibuchi
Publikováno v:
Japanese journal of infectious diseases. 72(3)
Mucormycosis is an opportunistic infection occurring in immunocompromised hosts with hematological malignancies. Mortality due to mucormycosis in patients with hematological malignancies is high. However, the clinical symptoms of mucormycosis are poo
Autor:
Eigo Shimizu, Sousuke Nakamura, Satoru Miyano, Mika Ito, Miho Ogawa, Nozomi Yokoyama, Tomomi Takei, Arinobu Tojo, Seiya Imoto, Kazuaki Yokoyama, Rika Kasajima, Rui Yamaguchi, Asako Kobayashi
Acute myeloid leukemia (AML) is a clonal myeloid neoplasm that typically arises de novo; however, some cases evolve from a preleukemic state, such as myelodysplastic syndrome (MDS). Such secondary AMLs and those with typical MDS-related clinical feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a4327ff26d7b9dd17230fda6f32311
https://europepmc.org/articles/PMC6177645/
https://europepmc.org/articles/PMC6177645/
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Autor:
Tomomi, Takei, Tadao, Ishida, Masahiro, Ikeda, Sumito, Shingaki, Kanji, Miyazaki, Yumiko, Yoshiki, Yu, Abe, Kiyoshi, Okazuka, Seiko, Iki, Nobuhiro, Tsukada, Kenshi, Suzuki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(11)
IgE multiple myeloma (MM) is a rare subtype of MM characterized by an aggressive and poor prognosis. Although novel agents have improved the prognosis of MM, there are few case reports of IgE MM treated with these agents. A 53-year-old male patient p
Autor:
Maki Oiwa-Monna, Hiroto Ishii, Shinji Mochizuki, Satoshi Takahashi, Tomomi Takei, Yasuhiro Ebihara, Takaaki Konuma, Jun Ooi, Seiko Kato, Arinobu Tojo
Publikováno v:
Leukemia & Lymphoma. 57:103-109
The efficacy of second allogeneic stem cell transplantation (SCT2) using cord blood (CB) for patients with relapsed hematological malignancies after initial allogeneic stem cell transplantation (SCT1) is unknown. We analyzed the results of SCT2 using